Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Liabilities (2016 - 2021)

Historic Total Liabilities for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $671.3 million.

  • Neurocrine Biosciences' Total Liabilities fell 386.65% to $671.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $671.3 million, marking a year-over-year decrease of 386.65%. This contributed to the annual value of $608.5 million for FY2020, which is 905.69% down from last year.
  • Neurocrine Biosciences' Total Liabilities amounted to $671.3 million in Q3 2021, which was down 386.65% from $677.2 million recorded in Q2 2021.
  • Neurocrine Biosciences' Total Liabilities' 5-year high stood at $698.3 million during Q3 2020, with a 5-year trough of $42.2 million in Q1 2017.
  • In the last 5 years, Neurocrine Biosciences' Total Liabilities had a median value of $583.2 million in 2019 and averaged $540.7 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 94652.2% in 2018, then plummeted by 905.69% in 2020.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Total Liabilities stood at $445.5 million in 2017, then rose by 15.03% to $512.4 million in 2018, then soared by 30.59% to $669.1 million in 2019, then dropped by 9.06% to $608.5 million in 2020, then rose by 10.32% to $671.3 million in 2021.
  • Its last three reported values are $671.3 million in Q3 2021, $677.2 million for Q2 2021, and $640.8 million during Q1 2021.